{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-063143","form_type":"8-K","ticker":"BIO","cik":"0000012208","company_name":"BIO-RAD LABORATORIES, INC.","filed_at":"2022-03-02T23:59:59+00:00","discovered_at":"2026-05-14T18:04:05.628404+00:00","generated_at":"2026-06-27T02:17:49.091280+00:00","sec_items":["8.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Bio-Rad closes $1.2B senior notes offering (3.300% 2027 & 3.700% 2032)","bullets":["$400M 3.300% notes due 2027 and $800M 3.700% notes due 2032 issued at par.","Net proceeds of approximately $1.186 billion after underwriting discount and expenses.","Proceeds for general corporate purposes, including working capital, capex, and potential M&A.","Joint book-runners: Citigroup Global Markets, Goldman Sachs, J.P. Morgan Securities.","Closing date March 2, 2022; offering pursuant to shelf registration statement on Form S-3."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-063143","json":"https://secwatch.observer/filing/0001193125-22-063143.json","markdown":"https://secwatch.observer/filing/0001193125-22-063143.md","text":"https://secwatch.observer/filing/0001193125-22-063143.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/12208/000119312522063143/0001193125-22-063143-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/12208/000119312522063143/d254235d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T02:17:49.091280+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}